Proenkephalin as a Novel Prognostic Marker in Heart Failure Patients: A Systematic Review and Meta-Analysis

Over the last several years, the use of biomarkers in the diagnosis of patients with heart failure (HF) has skyrocketed. Natriuretic peptides are currently the most widely used biomarker in the diagnosis and prognosis of individuals with HF. Proenkephalin (PENK) activates delta-opioid receptors in c...

Descripción completa

Detalles Bibliográficos
Autores principales: Siranart, Noppachai, Laohasurayotin, Khamik, Phanthong, Tanattida, Sowalertrat, Walit, Ariyachaipanich, Aekarach, Chokesuwattanaskul, Ronpichai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003589/
https://www.ncbi.nlm.nih.gov/pubmed/36902318
http://dx.doi.org/10.3390/ijms24054887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003589/
https://www.ncbi.nlm.nih.gov/pubmed/36902318
http://dx.doi.org/10.3390/ijms24054887

Ejemplares similares